Actively Recruiting
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
Led by Novo Nordisk A/S · Updated on 2026-01-02
36
Participants Needed
1
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical study is to find out how the novel insulin NNC0363-1063 and a non-glucose carbohydrate used in food and beverage might interact in participants with type 1 diabetes and if co-administration of these substances is safe and tolerable. All participants will get a fixed dose of NNC0363-1063 and an oral administration of different amounts of the non-glucose carbohydrate in a random order during 4 interaction tests. The participants will be in this clinical study for about 5 to 12 weeks.
CONDITIONS
Official Title
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female participant of non-child bearing potential (surgically sterilized or postmenopausal)
- Age 18 to 64 years at signing informed consent
- Body mass index between 18.5 and 29.9 kg/m² at screening
- Diagnosed with type 1 diabetes mellitus at least 1 year before screening
- Treated with multiple daily insulin injections or continuous subcutaneous insulin infusion for at least 90 days before screening
- Glycated haemoglobin (HbA1c) less than or equal to 9.0% at screening
You will not qualify if you...
- Male of reproductive age not using adequate contraception or whose female partner is not using adequate contraception
- Any condition except mild, stable type 1 diabetes related conditions that might jeopardize safety or study compliance according to investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Profil Institut für Stoffwechselforschung GmbH
Neuss, Germany, 41460
Actively Recruiting
Research Team
N
Novo Nordisk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here